Physician profile
Sarah E Aultman
NPI 1245469709
$4,589.60
in general payments reported to CMS, 2019-2025
46 companies · $705 in 2025
The $705 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $555 · 2021: $713 · 2022: $987 · 2023: $991 · 2024: $157 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797 · Education: $55.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.97 |
| Education | $55.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $651.21 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $389.23 | 2021-2025 | |
| Bausch Health US, LLC | $377.55 | 2019-2024 | Aplenzin, Wellbutrin |
| Astellas Pharma US INC | $317.64 | 2019-2025 | Veozah, Myrbetriq |
| Myriad Women'S Health, INC. | $304.61 | 2023 | Myrisk |
| Millicent US INC | $268.95 | 2023-2025 | Intrarosa, Femlyv |
| Scynexis, INC. | $193.43 | 2021-2022 | |
| Myovant Sciences INC. | $180.41 | 2021-2022 | |
| Pfizer INC. | $174.01 | 2019-2023 | |
| Evofem Biosciences, INC. | $151.57 | 2020-2025 | Phexxi, Solosec, Phexx |
| Lupin INC. | $150.07 | 2019-2021 | |
| Exeltis, USA INC. | $144.20 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $125.11 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.39 | 2019-2025 | |
| Hologic Sales and Service, LLC | $91.93 | 2020-2023 | Aptima |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Aultman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.